TaurXhttps://www.prnewswire.com/in/news-releases/taurx-s-late-stage-clinical-trial-reaches-new-milestone-893482727.html
taurx press release here We should expect some big news in the next few days with regards to the phase 3 trials of TaurX (alzheimer's cure/delay). The carrying value is $35m and it owns about 4% of the company.
The top line results of the trial come out at the end of may which will give us a good idea if the investment is worth $400m or 0 at our share. in 2016 the thought were that Taurx will IPO at $15bn USD so the $400m i made up for illustrative purposes is based on an $8bn valuation or half of the original expectations.
Worth adding units in my opinion now as i've always internally carried TaurX as 0 and can participate in the upside if the results are positive.